BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12067251)

  • 1. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53.
    Yu D; Berlin JA; Penning TM; Field J
    Chem Res Toxicol; 2002 Jun; 15(6):832-42. PubMed ID: 12067251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection.
    Shen YM; Troxel AB; Vedantam S; Penning TM; Field J
    Chem Res Toxicol; 2006 Nov; 19(11):1441-50. PubMed ID: 17112231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance.
    Park JH; Gelhaus S; Vedantam S; Oliva AL; Batra A; Blair IA; Troxel AB; Field J; Penning TM
    Chem Res Toxicol; 2008 May; 21(5):1039-49. PubMed ID: 18489080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) by PAH o-quinones: involvement of reactive oxygen species and copper(II)/copper(I) redox cycling.
    Park JH; Gopishetty S; Szewczuk LM; Troxel AB; Harvey RG; Penning TM
    Chem Res Toxicol; 2005 Jun; 18(6):1026-37. PubMed ID: 15962938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol.
    Abedin Z; Sen S; Field J
    Chem Res Toxicol; 2012 Jan; 25(1):113-21. PubMed ID: 22053912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human aldo-keto reductases and the metabolic activation of polycyclic aromatic hydrocarbons.
    Penning TM
    Chem Res Toxicol; 2014 Nov; 27(11):1901-17. PubMed ID: 25279998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by the aldo-keto-reductases (AKRs) generate abasic sites, oxidized pyrimidines, and 8-oxo-dGuo via reactive oxygen species.
    Park JH; Troxel AB; Harvey RG; Penning TM
    Chem Res Toxicol; 2006 May; 19(5):719-28. PubMed ID: 16696575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells.
    Park JH; Mangal D; Tacka KA; Quinn AM; Harvey RG; Blair IA; Penning TM
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6846-51. PubMed ID: 18474869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of base excision repair genes OGG1, APN1 and APN2 in benzo[a]pyrene-7,8-dione induced p53 mutagenesis.
    Abedin Z; Louis-Juste M; Stangl M; Field J
    Mutat Res; 2013 Jan; 750(1-2):121-8. PubMed ID: 23117049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and biological activity of benzo[a]pyrene-7,8-dione. A genotoxic metabolite generated by dihydrodiol dehydrogenase.
    Flowers L; Bleczinski WF; Burczynski ME; Harvey RG; Penning TM
    Biochemistry; 1996 Oct; 35(42):13664-72. PubMed ID: 8885846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Mutagenesis by benzo[a]pyrene derived radical cations.
    Sen S; Bhojnagarwala P; Francey L; Lu D; Penning TM; Field J
    Chem Res Toxicol; 2012 Oct; 25(10):2117-26. PubMed ID: 22768918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism.
    Penning TM
    Chem Biol Interact; 1993 Oct; 89(1):1-34. PubMed ID: 8221964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase.
    Burczynski ME; Lin HK; Penning TM
    Cancer Res; 1999 Feb; 59(3):607-14. PubMed ID: 9973208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells.
    Palackal NT; Lee SH; Harvey RG; Blair IA; Penning TM
    J Biol Chem; 2002 Jul; 277(27):24799-808. PubMed ID: 11978787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycyclic aromatic hydrocarbon o-quinones inhibit the activity of the catalytic fragment of protein kinase C.
    Yu D; Kazanietz MG; Harvey RG; Penning TM
    Biochemistry; 2002 Oct; 41(39):11888-94. PubMed ID: 12269833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
    Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
    Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
    Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
    Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitous aldehyde reductase (AKR1A1) oxidizes proximate carcinogen trans-dihydrodiols to o-quinones: potential role in polycyclic aromatic hydrocarbon activation.
    Palackal NT; Burczynski ME; Harvey RG; Penning TM
    Biochemistry; 2001 Sep; 40(36):10901-10. PubMed ID: 11535067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
    Joseph P; Jaiswal AK
    Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.